Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Jul-24 8:16 PM View:  | Schimmelpennink Evert B. President, CEO and Secretary Director | Lenz Therapeutics, Inc. (LENZ) | 22-Jul-24 | Option Exercise | 45,000 | $1.04 | $46,800.00 | 100% 0 to 45.0K | |
| 15-May-24 4:13 PM View: | Chevallard Daniel R. Chief Financial Officer | Lenz Therapeutics, Inc. (LENZ) | 14-May-24 | Purchase | 3,188 | $15.68 | $49,987.80 | 100% 0 to 3.19K | |
| 14-May-24 5:29 PM View: | McCollum James W Director | Lenz Therapeutics, Inc. (LENZ) | 13-May-24 | Purchase | 31,332 | $15.99 | $501,093.00 | 5% 589.27K to 620.6K | |
| 25-Mar-24 8:33 PM View: | Odrich Marc Chief Medical Officer | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Grant | 99,599 | -- | -- | 100% 0 to 99.6K | |
| 25-Mar-24 8:48 PM View: | Ra Capital Management, LLC Director 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Grant | 3,245,780 | -- | -- | 515% 629.79K to 3.88M | |
| 25-Mar-24 8:42 PM View: | McCollum James W Director | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Grant | 95,034 | -- | -- | 100% 0 to 95.03K | |
| 25-Mar-24 4:30 PM View: | Versant Venture Capital Vi,... 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Acquisition (other) | 598,203 | -- | -- | 15% 3.94M to 4.54M | |
| 25-Mar-24 8:42 PM View: | McCollum James W Director | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Grant | 494,233 | $0.51 | $249,992.00 | 520% 95.03K to 589.27K | |
| 25-Mar-24 8:48 PM View: | Ra Capital Management, LLC Director 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Purchase | 998,009 | $15.03 | $15,000,100.00 | 26% 3.88M to 4.87M | |
| 13-Apr-22 7:40 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 12-Apr-22 | Purchase | 350,000 | $4.08 | $1,428,000.00 | 4% 8.15M to 8.5M | |
| 13-Apr-22 7:35 PM View: | Gutry Phil CHIEF BUSINESS OFFICER | Lenz Therapeutics, Inc. (LENZ) | 11-Apr-22 | Private Purchase | 5,000 | $4.01 | $20,050.00 | 2% 294.94K to 299.94K | |
| 13-Apr-22 7:40 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 11-Apr-22 | Private Purchase | 74,464 | $4.07 | $303,068.00 | < 1% 8.07M to 8.15M | |
| 25-Jan-22 2:30 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 24-Jan-22 | Purchase | 23,000 | $8.70 | $200,100.00 | < 1% 8.05M to 8.07M | |
| 25-Jan-22 2:30 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 21-Jan-22 | Private Purchase | 100,000 | $8.99 | $899,000.00 | 1% 7.95M to 8.05M | |
| 21-Jan-22 1:48 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 20-Jan-22 | Purchase | 43,105 | $8.92 | $384,497.00 | < 1% 7.91M to 7.95M | |
| 21-Jan-22 1:48 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 19-Jan-22 | Private Purchase | 54,565 | $9.24 | $504,181.00 | < 1% 7.85M to 7.91M | |
| 20-Dec-21 1:46 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 15-Dec-21 | Market Purchase | 22,329 | $10.19 | $227,532.00 | < 1% 7.83M to 7.85M | 14% |
| 24-Nov-21 1:31 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 22-Nov-21 | Market Purchase | 201,685 | $10.15 | $2,047,100.00 | 3% 7.63M to 7.83M | (9%) |
| 15-Oct-21 6:06 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 15-Oct-21 | Market Purchase | 2,300 | $12.49 | $28,727.00 | < 1% 7.63M to 7.63M | 2% |
| 15-Oct-21 6:06 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 14-Oct-21 | Market Purchase | 3,100 | $12.50 | $38,750.00 | < 1% 7.62M to 7.63M | 2% |
| 15-Oct-21 6:06 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 13-Oct-21 | Market Purchase | 45,400 | $13.22 | $600,188.00 | < 1% 7.58M to 7.62M | (4%) |
| 08-Oct-21 5:09 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 08-Oct-21 | Market Purchase | 75,000 | $13.12 | $984,000.00 | < 1% 7.5M to 7.58M | |
| 08-Oct-21 5:09 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 07-Oct-21 | Market Purchase | 9,021 | $14.94 | $134,774.00 | < 1% 7.49M to 7.5M | < 1% |
| 08-Oct-21 5:09 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 06-Oct-21 | Market Purchase | 61,475 | $13.83 | $850,199.00 | < 1% 7.43M to 7.49M | 9% |
| 01-Jul-21 7:00 PM View: | Gutry Phil CHIEF BUSINESS OFFICER | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 8,126 | -- | -- | 3% 285.35K to 293.47K | |
| 01-Jul-21 7:00 PM View: | Jimenez Joseph Director | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 8,126 | -- | -- | 5% 153.81K to 161.94K | |
| 01-Jul-21 7:01 PM View: | Versant Venture Capital Vi,... 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 1,527,720 | -- | -- | 10% 14.71M to 16.24M | |
| 01-Jul-21 7:00 PM View: | Shah Smital Director | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Purchase | 5,882 | $17.00 | $99,994.00 | 100% 0 to 5.88K | |
| 01-Jul-21 5:39 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 6,931,620 | -- | -- | 100% 0 to 6.93M | |
| 01-Jul-21 7:01 PM View: | Jerel Davis Director 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 13,871,400 | -- | -- | 587% 2.36M to 16.24M | |
| 01-Jul-21 7:00 PM View: | Karsen Perry A Director | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 8,126 | -- | -- | 5% 155.91K to 164.03K | |
| 01-Jul-21 5:39 PM View: | Samsara Biocapital, L.P. 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Purchase | 500,000 | $17.00 | $8,500,000.00 | 7% 6.93M to 7.43M | |
| 01-Jul-21 7:01 PM View: | Versant Venture Capital Vi,... 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Purchase Duplicate | 180,000 | $17.00 | $3,060,000.00 | 1% 16.24M to 16.42M | |
| 01-Jul-21 7:00 PM View: | Lehrer-Graiwer Joshua PRESIDENT AND CEO Director | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 8,126 | -- | -- | < 1% 1.15M to 1.16M | |
| 01-Jul-21 7:01 PM View: | Stultz Katherine V CHIEF OPERATING OFFICER | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 8,126 | -- | -- | 4% 207.89K to 216.02K | |
| 01-Jul-21 7:01 PM View: | Versant Venture Capital Vi,... 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Conversion | 12,343,700 | -- | -- | 522% 2.36M to 14.71M | |
| 01-Jul-21 7:01 PM View: | Jerel Davis Director 10% Owner | Lenz Therapeutics, Inc. (LENZ) | 29-Jun-21 | Purchase | 180,000 | $17.00 | $3,060,000.00 | 1% 16.24M to 16.42M | |
| 01-Jul-21 7:00 PM View: | Gutry Phil CHIEF BUSINESS OFFICER | Lenz Therapeutics, Inc. (LENZ) | 18-Apr-21 | Option Exercise | 3,383 | $6.11 | $20,670.10 | 1% 281.96K to 285.35K | |
| 01-Jul-21 7:00 PM View: | Lehrer-Graiwer Joshua PRESIDENT AND CEO Director | Lenz Therapeutics, Inc. (LENZ) | 16-Jan-21 | Option Exercise | 374,013 | $0.30 | $112,204.00 | 48% 779.53K to 1.15M | |
| 01-Jul-21 7:00 PM View: | Gutry Phil CHIEF BUSINESS OFFICER | Lenz Therapeutics, Inc. (LENZ) | 15-Jan-21 | Option Exercise | 91,406 | $0.30 | $27,421.80 | 48% 190.56K to 281.96K | |
| 01-Jul-21 7:00 PM View: | Jimenez Joseph Director | Lenz Therapeutics, Inc. (LENZ) | 14-Jan-21 | Option Exercise | 49,876 | $0.30 | $14,962.80 | 48% 103.94K to 153.81K |
